Design of Clinical Trials

Breeden C. J. Hall T. C. Tyler H. R. : Herpes Simplex Encephalitis Treated with Systemic 5-Iodo-2′-Deoxyuridine. Ann. Intern. Med. 65:1050–1056, 1966.

Nolan D. C. Carruthers M. M. Lerner A. M. : Herpes virus hominis encephalitis in Michigan: Report of Thirteen Cases, Including Six Treated with Idoxuridine. N. Engl. J. Med. 282:10–13, 1970.

Boston Interhospital Virus Study Group and the NIAID-Sponsored Cooperative Antiviral Clinical Study: Failure of High Dose 5-Iodo-2′-Deoxyuridine in the Therapy of Herpes Simplex Virus Encephalitis. N. Engl. J. Med. 292(12):599–603, 1975.

Galasso G. : Perspectives in Antivirale. ASM News 45(7):353–358, 1979.

The Anturane Reinfarction Trial Research Group: Sulfinpyrazone in the Prevention of Sudden Death After Myocardial Infarction. N. Engl. J. Med. 302(5):250–256, 1980.

Temple R. Pledger G. : Special Report: The FDA's Critique of the Anturane Reinfarction Trial. N. Engl. J. Med. 303(25):1488–1492, 1980.

Kolata G. : FDA Says No to Anturane. Science 208:1130–1132, June 6, 1980.

Silverman W. A. : The Lesson of Retrolental Fibroplasia. Sci. Am. 236(6):101–107, 1977.

Welling P. G. : Effect of Food on Bioavailability of Drugs. Pharmacy International pp. 14–18, Jan. 1980.

Welling P. G. Huang H. Hewitt P. F. Lyons L. L. : Bioavailability of Erythromycin Stearate: Influence of Food and Fluid Volume. J. Pharm. Sci. 67(6):764–766, June 1978.

Welling P. G. Lyon L. L. Tse F. L. S. Craig W. A. : Propoxyphene and Norpropoxyphene: Influence of Diet and Fluid on Plasma Levels. Clin. Pharm. Ther. 19(5, Part I):559–565, 1976.

Food and Drug Administration, Div. of Pharmaceutics, Drug Monographs/Bureau of Drugs. Introduction to Guidelines for Bioavailability Studies, Revised March 30, 1977.

Kolata G. : NIH Shaken by Death of Research Volunteer. Science 209:475–478, July 1980.

Lab Report for Physicians. Vol. 2(6) Issue 8, June 1980.

Joubert P. Rivera-Calimlim L. Lasagna L. : The Normal Volunteer in Clinical Investigation: How Rigid Should Selection Criteria Be? Clin Pharm. Ther. 17(3):253–257, 1975.

Frieman J. A. Chalmers T. C. Smith H. Kuebler R. : The Importance of Beta, The Type II Error and Sample Size in the Design and Interpretation of the Randomized Control Trial. N. Engl. J. Med. 299:690–694, 1978.

Flethcher R. H. Fletcher S. W. : Clinical Research in General Medical Journals. N. Engl. J. Med. 301:180–183, 1979.

Schor S. S. : Statistical Problems in Clinical Trials. Am. J. Med. 55(6):727, Dec. 1973.

Cornfield J. : The University Group Diabetes Program: A Further Statistical Analysis of the Mortality Findings. JAMA 217(12):1676–1687, Sept. 20, 1971.

Doll R. Peto R. : Randomized Controlled Trials and Retrospective Controls. Br. J. Med. 280:44, 1980.